Clinical Trial Update: Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing selective internal radiation therapy (SIRT) with transarterial chemoembolisation (TACE) for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED